ROYAL BANK OF CANADA - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 40 filers reported holding AIM IMMUNOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$0301
-2.3%
0.00%
Q2 2023$0308
+2980.0%
0.00%
Q1 2023$010
+66.7%
0.00%
Q4 2022$06
-98.6%
0.00%
Q3 2022$0443
+44200.0%
0.00%
Q1 2022$010.0%0.00%
Q4 2021$01
-92.9%
0.00%
Q2 2021$014
+600.0%
0.00%
Q3 2020$0
-100.0%
2
-99.9%
0.00%
Q1 2020$5,0002,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
XTX Topco Ltd 29,269$63,0000.02%
SeaCrest Wealth Management, LLC 43,563$94,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,000$529,0000.01%
Lehman & Derafelo Financial Resources LLC 11,100$24,0000.01%
WINTON GROUP Ltd 54,894$118,0000.01%
Traynor Capital Management, Inc. 11,777$24,0000.00%
Community Bank, N.A. 13,226$28,0000.00%
SNS Financial Group, LLC 10,000$22,0000.00%
Verition Fund Management LLC 108,000$232,0000.00%
Schonfeld Strategic Advisors LLC 23,100$49,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders